Evaluation of botolinum toxin on preventing of scar

Evaluation of the effect of botolinum toxin A on preventing of abdominoplasty and mamoplasty surgery scar

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180826040876N1

Enrollment

Registered

2018-12-01

Start date

2018-07-23

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scar. Hypertrophic scar

Interventions

Intervention group: two weeks after surgery Botox will be injected at one side and normal saline at the other side.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with mammoplasty and abdominoplasty scar, operated during past 10 days

Exclusion criteria

Exclusion criteria: Allergy to botox Pregnancy and breastfeeding History of radiotherapy and chemotherapy Neuromotor diseases

Design outcomes

Primary

Measure	Time frame
Modified Stony Brook Scar Evaluation Scale. Timepoint: 3&6 month after injection. Method of measurement: Including 4 factors: width, height, scar color and incision line. scoring is based on 0-8.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNeda mehdizade rayeni

Tehran University of Medical Sciences

nedashervin95@gamil.com+98 21 5562 0300

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026